BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Innate Pharma 

Grand Pré
119/121 Ancien Chemin De Cassis
Marseille      France
Phone: 33-0-4-96-19-05-50 Fax: 33-04-96-19-05-55


SEARCH JOBS










 Company News
Innate Pharma (IPH.PA ) Strikes Cancer Pact Worth $1.275 Billion With Pharma Giant AstraZeneca PLC (AZN) 4/24/2015 6:04:49 AM
Innate Pharma (IPH.PA ) : DSMB Recommends Continuation Of Effikir Trial With Two Arms 3/30/2015 6:54:50 AM
Innate Pharma (IPH.PA ) Collaborates With NCIC Clinical Trials Group On The Phase I/II Trial Of IPH2201 In Ovarian Cancer 3/9/2015 7:30:38 AM
Innate Pharma (IPH.PA ) : Annual Results 2014: Stronger Cash Position And Expanded Clinical Portfolio 2/19/2015 8:34:09 AM
Innate Pharma (IPH.PA ): First Phase 2 Trial With IPH2201 Open In Head And Neck Cancer 12/19/2014 7:44:26 AM
Innate Pharma (IPH.PA ) Announces Its 2015 Financial Calendar As Well As Its Participation In Upcoming Investor Conferences 12/5/2014 10:29:46 AM
Innate Pharma (IPH.PA ) : IPH4102 Preclinical Data Published In "Cancer Research" 11/3/2014 8:45:18 AM
Innate Pharma (IPH.PA ) Presents Two Posters On Proprietary BTG-ADC Technology At The World ADC Summit 10/28/2014 7:12:25 AM
Innate Pharma (IPH.PA ) : Initiation Of A Phase I Clinical Trial Of Lirilumab In Combination With Elotuzumab 10/1/2014 10:14:53 AM
Innate Pharma (IPH.PA ): First Half Of 2014: Broadened Clinical Portfolio And Strengthened Cash Position 9/17/2014 7:47:35 AM
123456